Olson E J, Standing J E, Griego-Harper N, Hoffman O A, Limper A H
Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Infect Immun. 1996 Sep;64(9):3548-54. doi: 10.1128/iai.64.9.3548-3554.1996.
beta-Glucans are polymers of D-glucose which represent major structural components of fungal cell walls. It was shown previously that fungi interact with macrophages through beta-glucan receptors, thereby inducing release of tumor necrosis factor alpha (TNF-alpha). Additional studies demonstrated that vitronectin, a host adhesive glycoprotein, binds to fungi and enhances macrophage recognition of these organisms. Since vitronectin contains a carbohydrate-binding region, we postulated that vitronectin binds fungal beta-glucans and subsequently augments macrophage TNF-alpha release in response to this fungal component. To study this, we first determined the release of TNF-alpha from alveolar macrophages stimulated with fungal beta-glucan. Maximal TNF-alpha release occurred with moderate concentrations of beta-glucan (100 to 200 micrograms/ml), whereas higher concentrations of beta-glucan (> or = 500 micrograms/ml) caused apparent suppression of the TNF-alpha activity released. This suppression of TNF-alpha activity by high concentrations of beta-glucan was mediated by the particulate beta-glucan binding soluble TNF-alpha, through the lectin-binding domain of the cytokine, rendering the TNF-alpha less available for measurement. Next, we assessed the interaction of vitronectin with beta-glucan. Binding of 125I-vitronectin to particulate fungal beta-glucan was dose dependent and specifically inhibitable by unlabeled vitronectin. Furthermore, treatment of beta-glucan with vitronectin substantially augmented macrophage TNF-alpha release in response to this fungal component. These findings demonstrate that fungal beta-glucan can directly modulate TNF-alpha release from macrophages. Further, these studies indicate that the host adhesive glycoprotein vitronectin specifically binds beta-glucan and augments macrophage cytokine release in response to this fungal element.
β-葡聚糖是D-葡萄糖的聚合物,是真菌细胞壁的主要结构成分。先前的研究表明,真菌通过β-葡聚糖受体与巨噬细胞相互作用,从而诱导肿瘤坏死因子α(TNF-α)的释放。进一步的研究表明,玻连蛋白(一种宿主黏附糖蛋白)与真菌结合,并增强巨噬细胞对这些生物体的识别。由于玻连蛋白含有一个碳水化合物结合区域,我们推测玻连蛋白与真菌β-葡聚糖结合,随后增强巨噬细胞对这种真菌成分的TNF-α释放反应。为了研究这一点,我们首先测定了用真菌β-葡聚糖刺激的肺泡巨噬细胞中TNF-α的释放。中等浓度的β-葡聚糖(100至200微克/毫升)可使TNF-α释放达到最大值,而较高浓度的β-葡聚糖(≥500微克/毫升)则明显抑制TNF-α活性的释放。高浓度β-葡聚糖对TNF-α活性的这种抑制作用是由颗粒状β-葡聚糖结合可溶性TNF-α介导的,通过细胞因子的凝集素结合结构域,使TNF-α难以被检测到。接下来,我们评估了玻连蛋白与β-葡聚糖的相互作用。125I-玻连蛋白与颗粒状真菌β-葡聚糖的结合呈剂量依赖性,且可被未标记的玻连蛋白特异性抑制。此外,用玻连蛋白处理β-葡聚糖可显著增强巨噬细胞对这种真菌成分的TNF-α释放反应。这些发现表明,真菌β-葡聚糖可直接调节巨噬细胞中TNF-α的释放。此外,这些研究表明,宿主黏附糖蛋白玻连蛋白特异性结合β-葡聚糖,并增强巨噬细胞对这种真菌成分的细胞因子释放反应。